Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Celia

Celia Andreu Agulló, Valencia ES

Patent application numberDescriptionPublished
20100047212USE OF THE PEDF FACTOR TO INDUCE CELL REGENERATION - Use of the PEDF factor to induce cell regeneration. The present invention refers to the use of the molecule PEDF for the manufacture of medicines to activate processes included in the group of regenerative processes, such as skin regeneration, wound healing, cell therapy for cardiac, neural, or hematopoietic regeneration. It also refers to the manufacture/use of pharmaceutical compounds that contain an efficient quantity of the PEDF factor for stem cell self-renewal.02-25-2010

Celia Andreu Agulló, Valencia ES

Patent application numberDescriptionPublished
20100047212USE OF THE PEDF FACTOR TO INDUCE CELL REGENERATION - Use of the PEDF factor to induce cell regeneration. The present invention refers to the use of the molecule PEDF for the manufacture of medicines to activate processes included in the group of regenerative processes, such as skin regeneration, wound healing, cell therapy for cardiac, neural, or hematopoietic regeneration. It also refers to the manufacture/use of pharmaceutical compounds that contain an efficient quantity of the PEDF factor for stem cell self-renewal.02-25-2010

Celia De Austria De Luque, Madrid ES

Patent application numberDescriptionPublished
20090069430DIBENZENE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS - The invention is directed to a compound of formula (I)03-12-2009
20100041665N-PHENYL-PRENYLAMINE DERIVATIVES FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS - The present invention is related to a family of N-phenyl-prenylamine derivatives of formula (I), and to their use in the treatment of cognitive, neurodegenerative or neuronal diseases or disorders, such as Alzheimer's disease or Parkinson's Disease. The present invention also relates to pharmaceutical compositions comprising the same. Further, the present invention is directed to the use of the compounds in the manufacture of a medicament for the treatment and/or prevention of a cognitive, neurodegenerative or neuronal disease or disorder.02-18-2010
20100267827PHENYL-PRENYL-ETHER DERIVATIVES FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS - The present invention is related to a family of phenyl-prenyl-ether derivatives of formula (I), and to their use in the treatment of cognitive, neurodegenerative or neuronal diseases or disorders, such as Alzheimer's disease or 5 Parkinson's Disease. The present invention also relates to pharmaceutical compositions comprising the same. Further, the present invention is directed to the use of the compounds in the manufacture of a medicament for the treatment and/or prevention of a cognitive, neurodegenerative or neuronal disease or disorder.10-21-2010

Patent applications by Celia De Austria De Luque, Madrid ES

Celia De Lurdes Martins Carvalho De Pinho, Roge PT

Patent application numberDescriptionPublished
20090107517Device for Making Hair Streaks, Nuances and Luminosities04-30-2009

Celia Guillem López, Valencia ES

Patent application numberDescriptionPublished
20110293837COMPOSITION AND PROCEDURE FOR APPLYING PHASE CHANGE MATERIALS (PCMS) TO NATURAL STONE - The present invention relates to a composition of phase change materials (PCMs) and to the application thereof to natural stone in order to improve the thermal properties of same. Different PCMs are used depending on the type of stone and the manner in which they are introduced into or applied to the stone. The use of PCMs in powder form, emulsions, etc., depends on the porosity of the stone and the manner in which the PCMs are applied. PCMs are added to natural stone: as a surface layer on the stone, as a mastic applied to the posterior surface of the natural stone, as a reinforcing layer (for example in the form of mortar) applied to the posterior surface of the natural stone, or by impregnation through immersion of the stone in a PCMcontaining solution.12-01-2011

Celia Lafuente Blanco, Madrid ES

Patent application numberDescriptionPublished
20110118251SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS - An ORL-1 receptor antagonist of the formula:05-19-2011

Celia Maqueda Porras, Estafeta-Puerto ES

Patent application numberDescriptionPublished
20110065582ENVIRONMENTALLY FRIENDLY SLOW-RELEASE PESTICIDE FORMULATIONS - The present invention relates to a slow-release pesticide system in agrarian applications that includes but is not limited solely to insecticide, fungicide and herbicide formulations. The system includes a pesticide incorporated into vesicles that is formed by neutral lipids (thereby enhancing the water solubility of the pesticide). The vesicles that incorporate the pesticide are, in turn, adsorbed, on a clay mineral. The formulations are appropriate for pesticide molecules of any type (hydrophobic, acid and basic). Said pesticide formulation allows slow release of the active ingredient, thereby reducing the risk of pollution of groundwater and surface water.03-17-2011

Celia Prilleltensky-Milstein, Cambridge GB

Patent application numberDescriptionPublished
20080318836sCD Fingerprints - The present invention relates to the use of cluster of differentiation (CD) molecules in detecting the presence and progression of one or more disease states in an individual. In particular it relates to the use of profiles of shed CD (sCD) molecules in detecting an assessing the progress of one or more disease states in an individual. Further uses of sCD profiles according to the present invention are also described.12-25-2008
20090181863SCD Fingerprints - This invention relates to methods of testing, diagnosing, monitoring, prognostically stratifying and classifying disease, disorders and other medical conditions and physiological states through the detection and analysis of soluble CD antigens in a body fluid sample.07-16-2009

Patent applications by Celia Prilleltensky-Milstein, Cambridge GB

Celia Rogero Blanco, Torrejon De Ardoz ES

Patent application numberDescriptionPublished
20110039255METHOD AND SYSTEM FOR DETECTION OF A SELECTED TYPE OF MOLECULES IN A SAMPLE - The present invention refers to a method for detecting molecules and/or substances within a sample based on the use of a microcantilever system. The method comprises the variation of a certain condition such as humidity so as the mechanical feature analysed varies with a characteristic pattern while the target molecule is bound to the detector. The invention also refers to the system used to carry out such method.02-17-2011

Celia Rushford, Calgary CA

Patent application numberDescriptionPublished
20120123877POINT OF INTEREST TRACKING WITH SPECIFIC RETAILER ACCREDITATION - A method and system is provided for crediting presenters of product advertisements for purchases related to a consumer's initial point of interest. A presenter provides a previously generated, point of interest tracking (POIT) code on advertising media, the POIT code having an internet address for fulfillment website site, and the indentify of the presenter embedded therein. A consumer scans the POIT Code on an e-device and establishes communication with the fulfillment website, the presenter identity being extracted and tracked, any purchases thereafter being credited to the presenter. Vendors can now identify and remunerate an initial retailer or presenter for their role in closing the cycle from a consumer's point-of-interest through purchase.05-17-2012

Celia Sanchez Ramos, Madrid ES

Patent application numberDescriptionPublished
20080297931ELEMENT FOR USE ON THE TRANSPARENT SURFACES OF BUILDINGS FOR EYE PROTECTION AND THERAPY - Element for the protection and therapy of eyes applied to the transparent vertical surfaces of buildings. The invention is prepared by applying a yellow pigmented filter to the transparent or translucent surfaces of a building in which a subject may be found, and is designed to protect the eyes from the short wavelengths of the visible spectrum in the range 500 to 380 nm. The invention avoids the difficulties and risks of existing ways of protecting healthy eyes or eyes subjected to cataract surgery, and improves the protection of eyes suffering neurodegeneration, simply by applying a filter to the transparent or translucent surfaces of any building in which a subject may be found to provide protection against the neurodegenerative components of light (short wavelengths).12-04-2008
20090046244SAFETY HELMET VISOR WITH A TREATED SURFACE FOR EYE PROTECTION AND THERAPY - The invention is a filtering, transparent device for preventing damage to healthy eyes and for the prophylaxis and therapy of pseudophakic eyes and/or eyes with macular and retinal neurodegeneration. It is characterized by being the result of applying a yellow filter to the transparent or translucent surface(s) of the visor of a protective helmet, to protect the eyes from the short wavelengths of the visible spectrum (500 to 380 nm). Several possible uses are indicated such as for motorcyclists, in sports, and occupational uses.02-19-2009
20100282266MATERIAL FOR COVERING, COATING OR SCREENING FOR EYE PROTECTION AND THERAPY AGAINST THE EFFECTS OF BLUE LIGHT - The subject of the invention is a covering filtering material for protecting eyes which are healthy, pseudo-aphakic (operated for cataracts) and/or having retinal degeneration under shortwave lengths, which results from the application of a filter with yellow pigmentation on any covering, coating or screening material with the purpose of protecting the eyes from the shortwave lengths of visible spectrum from 500 to 380 nm which cause retinal degeneration. By way of example, this element may be applied in materials intended for manufacturing awnings, parasols or insulating materials or protection screens of any type. This invention avoids the difficulties and risks of the existing techniques for providing this protection for healthy and cataract-operated eyes and for improving protection for eyes undergoing neurodegenerative processes, achieving this with the simple application of a filter to common covering, coating or screening materials, thereby furnishing additional protection against neurodegenerative agents found in light (shortwave lengths).11-11-2010
20100309303PERSON RECOGNITION METHOD AND DEVICE INCORPORATING THE ANATOMIC LOCATION OF THE RETINA AS A BIOMETRIC CONSTANT, CORRESPONDING TO THE PHYSIOLOGICAL LOCATION OF THE PROJECTION OF THE VISUAL AXIS. - The invention relates to a person recognition method and device incorporating the anatomic location of the retina as a biometric constant, corresponding to the physiological location of the projection of the visual axis. More specifically, the invention relates to a person recognition method and a corresponding device incorporating the anatomic location of the retina as an exclusive discriminant biometric constant for each individual, corresponding to the physiological location of the visual axis, taking account of the physiological fixation disparity. The invention combines five elements, namely: an optical input system for examining the fundus of the eye, for example by means of retinal scanning or through the sclera; a system providing an expanded view of the retina, for example formed by converging lenses, diverging lenses and/or prisms or mirrors; a system for identifying and marking the anatomic point corresponding to the physiological point of the projection of the visual axis, such as a laser; a system of filters having different transmittance and optical density values; and a system for capturing and processing digital images, such as an optical digital camera. In addition, the invention can take the form of a portable, auto-focusing device with automatic control.12-09-2010
20110058712BIOMETRIC RECOGNITION THROUGH EXAMINATION OF THE SURFACE MAP OF THE SECOND OCULAR DIOPTRIC - The object of the invention is a method and the corresponding device thereof for recognition of persons incorporating, as biometric constant and determinant for each individual, the irregularities of the map of the posterior surface of the cornea, being different in each individual. The invention is based on taking an image exclusively of the second ocular dioptric with the objective of determining the irregularities of the surface map thereof with respect to a standardised surface (sphere, ellipsoid, torus, etc.) and quantifying them, yielding a set of attributes characteristic of each person utilised as a system of authentication, that is to say utilising the variations and calculations carried out therewith as biometric minutiae. Taking an image is of proven safety insofar as it may be taken without any contraindication whatsoever and as many times as necessary.03-10-2011
20120094308KIT AND METHOD FOR THE PREMORTEM IN VITRO DETECTION OF ALZHEIMER'S DISEASE - Kit and method for the pre mortem in vitro detection of Alzheimer's disease The invention relates to a detection kit for Alzheimer's disease based on the vitro identification of the presence of biomarkers in the remains normally discarded after crystalline lens surgery. The kit can be used for the pre mortem detection of the disease, even before the appearance of clinical symptoms. Among the available biomarkers, the biomarker of choice is beta-amyloid peptide, for which several methods of sample processing and labelling for the presence of the biomarker may be used. Embodied in the invention is also the use of the crystalline lens remains discarded during surgery, often cataract surgery, to prepare a method for the in vitro pre mortem detection of Alzheimer's disease.04-19-2012

Patent applications by Celia Sanchez Ramos, Madrid ES

Celia Sánchezramos, Madrid ES

Patent application numberDescriptionPublished
20110235361DEVICE AND METHOD FOR DIFFUSED LIGHTING FOR VEHICLE INTERIORS - This invention relates to a device for diffused lighting for vehicle interiors that includes one or more light sources and that is located outside the field of vision of the driver of the vehicle. Drivers, especially following refractive surgery, manifest debilitating effects and symptoms of dazzling. The mioisis caused by the diffused light of this invention improves the driver's visual performance, in terms of quality of vision.09-29-2011

Celia Sánchez Ramos, Madrid ES

Patent application numberDescriptionPublished
20100282266MATERIAL FOR COVERING, COATING OR SCREENING FOR EYE PROTECTION AND THERAPY AGAINST THE EFFECTS OF BLUE LIGHT - The subject of the invention is a covering filtering material for protecting eyes which are healthy, pseudo-aphakic (operated for cataracts) and/or having retinal degeneration under shortwave lengths, which results from the application of a filter with yellow pigmentation on any covering, coating or screening material with the purpose of protecting the eyes from the shortwave lengths of visible spectrum from 500 to 380 nm which cause retinal degeneration. By way of example, this element may be applied in materials intended for manufacturing awnings, parasols or insulating materials or protection screens of any type. This invention avoids the difficulties and risks of the existing techniques for providing this protection for healthy and cataract-operated eyes and for improving protection for eyes undergoing neurodegenerative processes, achieving this with the simple application of a filter to common covering, coating or screening materials, thereby furnishing additional protection against neurodegenerative agents found in light (shortwave lengths).11-11-2010
20100309303PERSON RECOGNITION METHOD AND DEVICE INCORPORATING THE ANATOMIC LOCATION OF THE RETINA AS A BIOMETRIC CONSTANT, CORRESPONDING TO THE PHYSIOLOGICAL LOCATION OF THE PROJECTION OF THE VISUAL AXIS. - The invention relates to a person recognition method and device incorporating the anatomic location of the retina as a biometric constant, corresponding to the physiological location of the projection of the visual axis. More specifically, the invention relates to a person recognition method and a corresponding device incorporating the anatomic location of the retina as an exclusive discriminant biometric constant for each individual, corresponding to the physiological location of the visual axis, taking account of the physiological fixation disparity. The invention combines five elements, namely: an optical input system for examining the fundus of the eye, for example by means of retinal scanning or through the sclera; a system providing an expanded view of the retina, for example formed by converging lenses, diverging lenses and/or prisms or mirrors; a system for identifying and marking the anatomic point corresponding to the physiological point of the projection of the visual axis, such as a laser; a system of filters having different transmittance and optical density values; and a system for capturing and processing digital images, such as an optical digital camera. In addition, the invention can take the form of a portable, auto-focusing device with automatic control.12-09-2010

Celia Taylor, Berkshire GB

Patent application numberDescriptionPublished
20080299521Colour Display System - A colour display system for aiding the selection and combination of colours in colour scheming is described, wherein the system comprises an array (12-04-2008